science1 distinct publisher
Ribosomes run nearly twice as fast on ac4C mRNA, putting the platform default in play
Johns Hopkins and NIH researchers report faster, cleaner translation from an alternative mRNA modification than from the chemistry used in COVID-19 mRNA vaccines. Dose economics is the open question.
Publishers:phys.org
Reality
- Evidence52
- Adoption
- Insufficient
- Hype gap+32
- Incentives62
- Confidence44